Avascular Necrosis of Femur Head
8
3
4
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (8)
Clinical Transformation of Bone Reconstruction With Autologous Bone Marrow Mesenchymal Stem Cells in Vitro to Repair Avascular Necrosis of Femur Head
Influence of Antiseptic Washes on Wound Healing Complications After THA
Comparison of the Efficacy of Pericapsular Nerve Group Block Alone Versus Pericapsular Nerve Group Block Combined With Superior Cluneal and Superior Gluteal Nerve Blocks in Patients Undergoing Hip Surgery
Investigation of the Effect of Hyperbaric Oxygen Therapy in Patients With Avascular Necrosis
Multicentre SMS Study - FR
Mesenchymal Stem Cells in Osteonecrosis of the Femoral Head
Autologous Osteoblastic Cells Implantation to Early Stage Osteonecrosis of the Femoral Head
Implantation of Bone Marrow Cells to Treat Avascular Necrosis of Femoral Head (ANFH)